afety and efficacy of 40 kDa peginterferon alfa-2A (PEGASYS®) in the treatment of patients co-infected with HIV and HCV: preliminary results from randomized, multicenter trial

Authors

M Khalili
Margaret Hoffman-Terry MD, FACP, Lehigh Valley Health NetworkFollow
T Hassanein
D Bernstein
G Harb

Publication/Presentation Date

10-2001

Volume

34

Issue

4

First Page

A328

Last Page

A328

Published In/Presented At

https://doi.org/10.1053/S0270-9139(00)82754-8

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article